Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/31877
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBehr, Jürgen-
dc.contributor.authorDemedts, Maurits-
dc.contributor.authorBuhl, Roland-
dc.contributor.authorCostabel, Ulrich-
dc.contributor.authorDekhuijzen, Richard P.N.-
dc.contributor.authorJansen, Henk M.-
dc.contributor.authorMacNee, William-
dc.contributor.authorTHOMEER, Michiel-
dc.contributor.authorWallaert, Benoit-
dc.contributor.authorLaurent, François-
dc.contributor.authorNicholson, Andrew G.-
dc.contributor.authorVerbeken, Eric K.-
dc.contributor.authorVerschakelen, Johny-
dc.contributor.authorFlower, C.D.R.-
dc.contributor.authorPetruzzelli, Stefano-
dc.contributor.authorDe Vuyst, Paul-
dc.contributor.authorvan den Bosch, J.M.M.-
dc.contributor.authorRodriguez-Becerra, Eulogio-
dc.contributor.authorLankhorst, Ida-
dc.contributor.authorSardina, Marco-
dc.contributor.authorBoissard, Gabrielle-
dc.date.accessioned2020-09-09T12:45:22Z-
dc.date.available2020-09-09T12:45:22Z-
dc.date.issued2009-
dc.date.submitted2020-08-05T08:41:05Z-
dc.identifier.citationRESPIRATORY RESEARCH, 10 (1) (Art N° 101)-
dc.identifier.urihttp://hdl.handle.net/1942/31877-
dc.description.abstractBackground: The randomized placebo-controlled IFIGENIA-trial demonstrated that therapy with high-dose N-acetylcysteine (NAC) given for one year, added to prednisone and azathioprine, significantly ameliorates (i.e. slows down) disease progression in terms of vital capacity (VC) (+9%) and diffusing capacity (DLco) (+24%) in idiopathic pulmonary fibrosis (IPF). To better understand the clinical implications of these findings we performed additional, explorative analyses of the IFGENIA data set.-
dc.language.isoen-
dc.titleLung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial-
dc.typeJournal Contribution-
dc.identifier.issue1-
dc.identifier.volume10-
local.bibliographicCitation.jcatA1-
local.contributor.corpauthorIfigenia Study Group-
local.publisher.placeCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnr101-
dc.identifier.doi10.1186/1465-9921-10-101-
dc.identifier.isiWOS:000271637700002-
dc.identifier.eissn1465-993X-
local.provider.typebibtex-
local.uhasselt.uhpubno-
item.fullcitationBehr, Jürgen; Demedts, Maurits; Buhl, Roland; Costabel, Ulrich; Dekhuijzen, Richard P.N.; Jansen, Henk M.; MacNee, William; THOMEER, Michiel; Wallaert, Benoit; Laurent, François; Nicholson, Andrew G.; Verbeken, Eric K.; Verschakelen, Johny; Flower, C.D.R.; Petruzzelli, Stefano; De Vuyst, Paul; van den Bosch, J.M.M.; Rodriguez-Becerra, Eulogio; Lankhorst, Ida; Sardina, Marco & Boissard, Gabrielle (2009) Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial. In: RESPIRATORY RESEARCH, 10 (1) (Art N° 101).-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
item.contributorBehr, Jürgen-
item.contributorDemedts, Maurits-
item.contributorBuhl, Roland-
item.contributorCostabel, Ulrich-
item.contributorDekhuijzen, Richard P.N.-
item.contributorJansen, Henk M.-
item.contributorMacNee, William-
item.contributorTHOMEER, Michiel-
item.contributorWallaert, Benoit-
item.contributorLaurent, François-
item.contributorNicholson, Andrew G.-
item.contributorVerbeken, Eric K.-
item.contributorVerschakelen, Johny-
item.contributorFlower, C.D.R.-
item.contributorPetruzzelli, Stefano-
item.contributorDe Vuyst, Paul-
item.contributorvan den Bosch, J.M.M.-
item.contributorRodriguez-Becerra, Eulogio-
item.contributorLankhorst, Ida-
item.contributorSardina, Marco-
item.contributorBoissard, Gabrielle-
crisitem.journal.eissn1465-993X-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
1465-9921-10-101.pdfPublished version1.05 MBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

77
checked on Nov 24, 2025

WEB OF SCIENCETM
Citations

56
checked on Nov 24, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.